| Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Cash and cash equivalents | 176 | 8 | 24 | 17 | 16 | 11 | 181 | 105 |
---|
Marketable securities | 118 | 191 | 104 | 57 | 36 | 55 | 136 | 3 |
---|
Due from related parties | - | 1 | 0 | 0 | - | - | 1 | 2 |
---|
Prepaid Expense and Other Assets, Current | - | 5 | 4 | 14 | 4 | 9 | 16 | 32 |
---|
Total current assets | - | 205 | 132 | 89 | 56 | 75 | 334 | 141 |
---|
Marketable securities, noncurrent | 55 | 88 | 30 | 6 | 1 | - | 1 | 1 |
---|
Property, plant and equipment, net | 6 | 19 | 77 | 77 | 61 | 54 | 83 | 144 |
---|
Intangible asset, net | - | 5 | 3 | 1 | - | - | 1 | 20 |
---|
Convertible note receivable | - | - | - | - | - | - | 6 | 7 |
---|
Operating Lease, Right-of-Use Asset | - | - | - | - | 12 | 13 | 36 | 46 |
---|
Other Assets, Noncurrent | 1 | 1 | 0 | 2 | 4 | 1 | 7 | 5 |
---|
Total assets | - | 317 | 250 | 182 | 143 | 152 | 469 | 362 |
---|
Accounts payable | 2 | 4 | 6 | 3 | 2 | 4 | 11 | 21 |
---|
Accrued expenses and other liabilities | - | - | - | - | - | - | 51 | 42 |
---|
Notes Payable, Related Parties, Current | - | - | - | - | - | - | - | 432 |
---|
Due to related parties | - | - | - | - | - | - | 4 | 3 |
---|
Operating Lease, Liability, Current | - | - | - | - | - | 6 | 3 | 3 |
---|
Total current liabilities | 6 | 13 | 21 | 27 | 12 | 25 | 369 | 501 |
---|
Notes Payable, Related Parties, Noncurrent | - | - | - | - | - | - | - | 241 |
---|
Operating Lease, Liability, Noncurrent | - | - | - | - | 11 | 10 | 37 | 48 |
---|
Warrant liability | - | - | - | - | - | - | - | 22 |
---|
Other liabilities | - | 0 | 0 | - | - | - | 0 | 0 |
---|
Total liabilities | - | 24 | 32 | 36 | 22 | 34 | 713 | 812 |
---|
Commitments and Contingencies | - | - | - | - | - | - | - | - |
---|
Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid-in capital | 607 | 681 | 718 | 741 | 783 | 872 | 1,720 | 1,931 |
---|
Accumulated deficit | - | -387 | -499 | -595 | -662 | -755 | -2,000 | -2,400 |
---|
Accumulated other comprehensive income | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 |
---|
Total ImmunityBio stockholders’ deficit | 356 | 293 | 219 | 146 | 121 | 117 | -242 | -447 |
---|
Noncontrolling interests | - | - | - | - | - | - | -2 | -2 |
---|
Total stockholders’ deficit | - | - | - | - | - | - | -244 | -450 |
---|
Total liabilities and stockholders’ deficit | - | 317 | 250 | 182 | 143 | 152 | 469 | 362 |
---|